Close
Oriana Haran, MD Plastic Surgery, Breast Reconstructive Surgery
A Phase 2, Randomized, Active-controlled, Open-label, Multicenter Study of
Belzutifan Plus Fulvestrant in Participants With Estrogen Receptor Positive, HER2 Negative Unresectable Locally Advanced or Metastatic Breast Cancer After Progression on Previous
This is a Phase 2, randomized, active-controlled, parallel-group, multisite, open-label studyof belzutifan plus fulvestrant versus everolimus plus ETPC (fulvestrant or exemestane) inparticipants with ER+/HER2- unresectable, locally advanced, or mBC.
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence—A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT)
This is a Phase 3, global, multicenter, randomized, open-label study.
Charles Fries, MD Plastic Surgery
Carissia Calvo–Strube, M.D. Surgical Oncology, Breast Surgical Oncology
Physical Therapy for Cancer
Physical therapy is a common treatment after surgery and for pain or other physical symptoms. Physical therapists assess your balance, movement and strength, then help you with special exercises to treat problems you have. You learn self-care strategies to help you enjoy a better quality of life.
Cancer patients are getting younger. Mays Cancer Center experts explain the modern factors at play
The risk of aging-related diseases, including cancer, doesn't sharply increase until the age of 50. Why then are so many younger people getting cancer right now?